China Life Sciences Licensing and Partnering Transactions

“Sidley Austin LLP fields a top-notch team handling a range of work in the life science space, including transactions, FCPA investigations and antitrust matters as well as related IP issues. It is particularly skilled in undertaking licensing as well as financing matters. The team advises international companies on corporate, regulatory, and compliance issues.”
Chambers Greater China Region, 2023

Types of Life Sciences Transactions:

We represent clients in life sciences licensing and collaboration transactions of all types, including:

Complex, Early-Stage Research and Development

• Target and compound discovery collaborations, including option-based deal structures
• Platform technology licensing
• Strategic business partnerships to develop and commercialize new therapies, pharmaceuticals, and products

Clinical-Stage

• Co-development arrangements, including combination therapies
• Single-asset licensing
• Clinical trial agreements
• Clinical manufacturing and supply agreements

Cross-Border

• Regional co-development and license agreements drawing on capabilities in the EU, the UK, and the U.S.

Commercial

• Co-commercialization, co-promotion, and marketing arrangements, leveraging our team of healthcare lawyers
• Commercial manufacturing and supply agreements, in concert with our GMP compliance and enforcement team

Support

• University research, development, and license agreements
• Non-exclusive license agreements
• Manufacturing process development, technology and know-how transfer, distribution, and other services agreements

Data-Driven

• Licensing and use of Big Data
• Advising clients on the convergence of artificial intelligence and therapeutic product discovery and development